EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
Slovenia flag Slovenia · Delayed Price · Currency is EUR
62.00
+2.00 (3.33%)
At close: Apr 28, 2026

EQUINOX NEPREMICNINE d.d. Revenue

EQUINOX NEPREMICNINE d.d. had revenue of 2.31M EUR in the quarter ending March 31, 2026, with 3.00% growth. This brings the company's revenue in the last twelve months to 9.44M, up 1.65% year-over-year. In the year 2025, EQUINOX NEPREMICNINE d.d. had annual revenue of 9.37M with 8.10% growth.

Revenue (ttm)
9.44M
Revenue Growth
+1.65%
P/S Ratio
11.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
110.66M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20259.37M702.00K8.10%
Dec 31, 20248.67M884.07K11.35%
Dec 31, 20237.79M442.80K6.03%
Dec 31, 20227.34M629.52K9.38%
Dec 31, 20216.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition